THE NAGA GROUP AG

Original-Research: THE NAGA GROUP AG (von NuWays AG): Buy

Original-Research: THE NAGA GROUP AG - from NuWays AG

Classification of NuWays AG to THE NAGA GROUP AG

Company Name: THE NAGA GROUP AG
ISIN: DE000A161NR7

Reason for the research: Update
Recommendation: Buy
from: 11.07.2024
Target price: EUR 1.20
Last rating change:
Analyst: Frederik Jarchow

FY23 out // Softer topline but strong EBITDA; chg.

Topic: NAGA recently reported FY23 figures that came with a slight miss on the topline and a positive
surprise on the bottom line. A D&A one-off makes EBIT look ugly. In detail:

Sales of € 39.7m (NAGA standalone), are below prelims of € 45.5m resulting from the lower than anticipated avg. revenue per trade of only € 4.3 (vs. eNuW: € 4.9) and 9.2m transactions (both NAGA standalone).

EBITDA came in higher than expected at € 8.4m (vs. prelims: € 7.0m), thanks to significantly lower
marketing expenses (€ 4.6m vs. eNuW: € 5.9m), personnel expenses (€ 6.5m vs eNuW: € 7.9m) andR&D costs (€ 3.4m vs. eNuW: € 5.2m) overcompensating for the weaker topline and higher other operating expenses (€ 9.8m vs. eNuW: € 5.9m). EBT of € -61m (vs. eNuW: € -2.4m), is mainly burdenedone-off amortization to the tune of € 57m as a result of the valuation related to the merger with capex.

Looking into 2024, the outlook for the joint Group shines bright: Trading activity of peers that seem to revitalize and cross-selling potentials between NAGA and capex should fuel the number of transactions to15.9m and hence sales to € 71.8m, assuming an avg. revenue per trade of € 5.0. Synergy effects and
ongoing disciplined spending are expected to additionally drive EBITDA to € 11.5m. As we do not expect further meaningful amortizations in FY24, EBIT should come in at € 1.6m (eNuW).

Going forward, management has ambitious growth plans expecting to generate USD 250m sales with a 40% EBITDA margin until FY26. While we think this is a rather optimistic scenario, the past has already shown that an incremental positive change of the public markets' sentiment could have an enormous effect on the P&L of NAGA. The leverage of the joint Group could even scale this effect. Still, in our base case scenario we conservatively only anticipating € 90m in sales and EBITDA of € 19m (22% EBITDA margin), leaving room for positive surprises.

Overall, the revitalization of customer activity in the brokerage space, paired with cross-selling and synergy effects arising from the merger should bode well for NAGA. Details of the growth plan should be unveiled during today´s CDM starting at 4pm CEST.

BUY with an unchanged PT of € 1.20 based on DCF.

You can download the research here:
http://www.more-ir.de/d/30193.pdf
For additional information visit our website www.nuways-ag.com/research.

Contact for questions
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++

-------------------transmitted by EQS Group AG.-------------------

The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.